Abstract: An automated mobile robot includes a housing, an articulated arm that has at least one UVC light thereon, an actuator that is operable to move the arm between a retracted position and an extended position, a drive unit that is operable to move the housing, a position sensor that is operable to generate position signals indicative of an instant position, a computer, and a battery connected to the actuator, the drive unit, the UVC light, and the computer. The computer is operably coupled to the actuator, the position sensor, the UVC light, and the drive unit. The computer has a predetermined disinfection route and is configured to operate the actuator to move the arm, activate and deactivate the UVC light, and operate the drive unit to move the housing along the predetermined disinfection route based on the instant position and a desired position in the predetermined disinfection route.

Abstract: Compounds of Formula (I) that act as cannabinoid receptor ligands and their uses in the treatment diseases, conditions and/or disorders modulated by cannabinoid receptor antagonists in animals are described herein.

Abstract: The present invention provides non-steroidal compounds of formula I which are selective modulators (i.e., agonists and antagonists) of a steroid receptor, specifically, the glucocorticoid receptor. The present invention also provides pharmaceutical compositions containing these compounds and methods for using these compounds to treat animals requiring glucocorticoid receptor agonist or antagonist therapy. Glucocorticoid receptor modulators are useful to the diseases, such as obesity, diabetes, inflammation and others as described below. The present invention also provides intermediates and processes for preparing these compounds.

Abstract: Compounds of Formula (I) are described herein. The compounds have been shown to act as cannabinoid receptor ligands and are therefore useful in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals.

Abstract: Compounds of Formula (I) are described herein. The compounds have been shown to act as cannabinoid receptor ligands and are therefore useful in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals.

Abstract: Compounds of Formula (I) and (II) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein.

Abstract: Compounds of Formula (I) and (II) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein.

Abstract: A process for preparing a compound of the formula wherein n, R1, R2, R3 and X are as defined above, used as an intermediate in the synthesis of ?-adrenergic receptor agonists.

Abstract: Compounds of Formula (I) are described herein. The compounds have been shown to act as cannabinoid receptor ligands and are therefore useful in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals.

Abstract: There is disclosed a method of controlling, and a control system for, an apparatus, such as a machine tool (100), for forming a straight configured contour, or a straight configured segment forming part of a curvilinear contour, and having co-ordinates in at least two directions (X, Y and Z), said apparatus incorporating a work piece support (102), a contour forming means, such as a milling cutter (107), incremental drives (M.sub.X, M.sub.Y and M.sub.